International Consensus Conference for Advanced Breast Cancer, Lisbon 2019

Standard

International Consensus Conference for Advanced Breast Cancer, Lisbon 2019 : ABC5 Consensus - Assessment by a German Group of Experts. / Thomssen, Christoph; Lüftner, Diana; Untch, Michael; Haidinger, Renate; Würstlein, Rachel; Harbeck, Nadia; Augustin, Doris; Briest, Susanne; Ettl, Johannes; Fasching, Peter A; Förster, Frank; Kurbacher, Christian M; Lück, Hans-Joachim; Marschner, Norbert; Müller, Lothar; Müller, Volkmar; Perlova-Griff, Lidia; Radke, Isabel; Ruckhäberle, Eugen; Scheffen, Iris; Schumacher-Wulf, Eva; Schwoerer, Moritz; Steinfeld-Birg, Dieter; Ziegler-Löhr, Katja.

In: BREAST CARE, Vol. 15, No. 1, 02.2020, p. 82-95.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Thomssen, C, Lüftner, D, Untch, M, Haidinger, R, Würstlein, R, Harbeck, N, Augustin, D, Briest, S, Ettl, J, Fasching, PA, Förster, F, Kurbacher, CM, Lück, H-J, Marschner, N, Müller, L, Müller, V, Perlova-Griff, L, Radke, I, Ruckhäberle, E, Scheffen, I, Schumacher-Wulf, E, Schwoerer, M, Steinfeld-Birg, D & Ziegler-Löhr, K 2020, 'International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus - Assessment by a German Group of Experts', BREAST CARE, vol. 15, no. 1, pp. 82-95. https://doi.org/10.1159/000505957

APA

Thomssen, C., Lüftner, D., Untch, M., Haidinger, R., Würstlein, R., Harbeck, N., Augustin, D., Briest, S., Ettl, J., Fasching, P. A., Förster, F., Kurbacher, C. M., Lück, H-J., Marschner, N., Müller, L., Müller, V., Perlova-Griff, L., Radke, I., Ruckhäberle, E., ... Ziegler-Löhr, K. (2020). International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus - Assessment by a German Group of Experts. BREAST CARE, 15(1), 82-95. https://doi.org/10.1159/000505957

Vancouver

Bibtex

@article{8177df6f9cc8458580c07deb46760f45,
title = "International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus - Assessment by a German Group of Experts",
abstract = "The 5th International Consensus Conference for Advanced Breast Cancer (ABC5) took place on November 14-16, 2019, in Lisbon, Portugal. Its aim is to standardize the treatment of advanced breast cancer based on the available evidence and to ensure that all breast cancer patients worldwide receive adequate treatment and access to new therapies. This year, the conference focused on developments and study results in the treatment of patients with hormone receptor-positive/HER2-negative breast cancer as well as precision medicine. As in previous years, patient advocates from around the world were integrated into the ABC conference and had seats on the ABC consensus panel. In the present paper, a working group of German breast cancer experts comments on the results of the on-site ABC5 consensus votes by ABC panelists regarding their applicability for routine treatment in Germany. These comments take the recommendations of the Breast Committee of the Gynecological Oncology Working Group (Arbeitsgemeinschaft Gyn{\"a}kologische Onkologie; AGO) into account. The report and assessment presented here pertain to the preliminary results of the ABC5 consensus. The final version of the statements will be published in Annals of Oncology and The Breast.",
author = "Christoph Thomssen and Diana L{\"u}ftner and Michael Untch and Renate Haidinger and Rachel W{\"u}rstlein and Nadia Harbeck and Doris Augustin and Susanne Briest and Johannes Ettl and Fasching, {Peter A} and Frank F{\"o}rster and Kurbacher, {Christian M} and Hans-Joachim L{\"u}ck and Norbert Marschner and Lothar M{\"u}ller and Volkmar M{\"u}ller and Lidia Perlova-Griff and Isabel Radke and Eugen Ruckh{\"a}berle and Iris Scheffen and Eva Schumacher-Wulf and Moritz Schwoerer and Dieter Steinfeld-Birg and Katja Ziegler-L{\"o}hr",
note = "Copyright {\textcopyright} 2020 by S. Karger AG, Basel.",
year = "2020",
month = feb,
doi = "10.1159/000505957",
language = "English",
volume = "15",
pages = "82--95",
journal = "BREAST CARE",
issn = "1661-3791",
publisher = "S. Karger AG",
number = "1",

}

RIS

TY - JOUR

T1 - International Consensus Conference for Advanced Breast Cancer, Lisbon 2019

T2 - ABC5 Consensus - Assessment by a German Group of Experts

AU - Thomssen, Christoph

AU - Lüftner, Diana

AU - Untch, Michael

AU - Haidinger, Renate

AU - Würstlein, Rachel

AU - Harbeck, Nadia

AU - Augustin, Doris

AU - Briest, Susanne

AU - Ettl, Johannes

AU - Fasching, Peter A

AU - Förster, Frank

AU - Kurbacher, Christian M

AU - Lück, Hans-Joachim

AU - Marschner, Norbert

AU - Müller, Lothar

AU - Müller, Volkmar

AU - Perlova-Griff, Lidia

AU - Radke, Isabel

AU - Ruckhäberle, Eugen

AU - Scheffen, Iris

AU - Schumacher-Wulf, Eva

AU - Schwoerer, Moritz

AU - Steinfeld-Birg, Dieter

AU - Ziegler-Löhr, Katja

N1 - Copyright © 2020 by S. Karger AG, Basel.

PY - 2020/2

Y1 - 2020/2

N2 - The 5th International Consensus Conference for Advanced Breast Cancer (ABC5) took place on November 14-16, 2019, in Lisbon, Portugal. Its aim is to standardize the treatment of advanced breast cancer based on the available evidence and to ensure that all breast cancer patients worldwide receive adequate treatment and access to new therapies. This year, the conference focused on developments and study results in the treatment of patients with hormone receptor-positive/HER2-negative breast cancer as well as precision medicine. As in previous years, patient advocates from around the world were integrated into the ABC conference and had seats on the ABC consensus panel. In the present paper, a working group of German breast cancer experts comments on the results of the on-site ABC5 consensus votes by ABC panelists regarding their applicability for routine treatment in Germany. These comments take the recommendations of the Breast Committee of the Gynecological Oncology Working Group (Arbeitsgemeinschaft Gynäkologische Onkologie; AGO) into account. The report and assessment presented here pertain to the preliminary results of the ABC5 consensus. The final version of the statements will be published in Annals of Oncology and The Breast.

AB - The 5th International Consensus Conference for Advanced Breast Cancer (ABC5) took place on November 14-16, 2019, in Lisbon, Portugal. Its aim is to standardize the treatment of advanced breast cancer based on the available evidence and to ensure that all breast cancer patients worldwide receive adequate treatment and access to new therapies. This year, the conference focused on developments and study results in the treatment of patients with hormone receptor-positive/HER2-negative breast cancer as well as precision medicine. As in previous years, patient advocates from around the world were integrated into the ABC conference and had seats on the ABC consensus panel. In the present paper, a working group of German breast cancer experts comments on the results of the on-site ABC5 consensus votes by ABC panelists regarding their applicability for routine treatment in Germany. These comments take the recommendations of the Breast Committee of the Gynecological Oncology Working Group (Arbeitsgemeinschaft Gynäkologische Onkologie; AGO) into account. The report and assessment presented here pertain to the preliminary results of the ABC5 consensus. The final version of the statements will be published in Annals of Oncology and The Breast.

U2 - 10.1159/000505957

DO - 10.1159/000505957

M3 - SCORING: Journal article

C2 - 32231503

VL - 15

SP - 82

EP - 95

JO - BREAST CARE

JF - BREAST CARE

SN - 1661-3791

IS - 1

ER -